RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @tadafumisugimo1: win ratio法を使った解析手法、心不全入院をのべ件数で比較、複数ある副次エンドポイントの有効性をどう補正するか、先行研究がことごとくコケているのに良い結果が出た時のメタ解析手法、など勉強になります。#CardioJapan htt…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
@krychtiukmd @JACCJournals Here it is. https://t.co/6PTEzwJoxT
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
Statistical Appraisal of 6 Recent Clinical Trials in Cardiology https://t.co/wNy4tJuPjJ
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @MasriAhmadMD: A statistical appraisal of #Tafamidis #ATTR-ACT trial #CardioTwitter #amyloidosis https://t.co/S4DhD7TJjM https://t.c…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @tadafumisugimo1: win ratio法を使った解析手法、心不全入院をのべ件数で比較、複数ある副次エンドポイントの有効性をどう補正するか、先行研究がことごとくコケているのに良い結果が出た時のメタ解析手法、など勉強になります。#CardioJapan htt…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
win ratio法を使った解析手法、心不全入院をのべ件数で比較、複数ある副次エンドポイントの有効性をどう補正するか、先行研究がことごとくコケているのに良い結果が出た時のメタ解析手法、など勉強になります。#CardioJapan https://t.co/Q6d0IrUP85
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @f2harrell: Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again tha…
RT @MasriAhmadMD: A statistical appraisal of #Tafamidis #ATTR-ACT trial #CardioTwitter #amyloidosis https://t.co/S4DhD7TJjM https://t.c…
Excellent reassessment of 6 recent cardiovascular trials making many points re:statistical design and pointing out again that clinical investigators pay a price when they start a trial without being bold enough to use new statistical methods for handling m
A statistical appraisal of #Tafamidis #ATTR-ACT trial #CardioTwitter #amyloidosis https://t.co/S4DhD7TJjM https://t.co/Iye7OabvbB
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
RT @alikaragozmd: What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal…
What is new for that study ? by Stuart Pocock https://t.co/37GnPQ8Rx8 … @ihtanboga @ADAlthousePhD @f2harrell @TKDsosyal @boback https://t.co/lOuUyXSbgH